0001104659-21-113036.txt : 20210907
0001104659-21-113036.hdr.sgml : 20210907
20210903185137
ACCESSION NUMBER: 0001104659-21-113036
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210907
DATE AS OF CHANGE: 20210903
EFFECTIVENESS DATE: 20210907
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bakx Therapeutics, Inc.
CENTRAL INDEX KEY: 0001876494
IRS NUMBER: 851864174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-412464
FILM NUMBER: 211237843
BUSINESS ADDRESS:
STREET 1: 551 MT GUARDIAN RD EXT
STREET 2: PO BOX 398
CITY: BEARSVILLE
STATE: NY
ZIP: 12409
BUSINESS PHONE: (718) 419-5221
MAIL ADDRESS:
STREET 1: 551 MT GUARDIAN RD EXT
STREET 2: PO BOX 398
CITY: BEARSVILLE
STATE: NY
ZIP: 12409
D
1
primary_doc.xml
X0708
D
LIVE
0001876494
Bakx Therapeutics, Inc.
551 MT GUARDIAN RD EXT
BEARSVILLE
NY
NEW YORK
12409
(718) 419-5221
DELAWARE
None
None
Corporation
true
2020
Sree
Kant
551 Mt Guardian Rd Ext
PO Box 398
Bearsville
NY
NEW YORK
12409
Executive Officer
Director
Promoter
Yibing
Shan
c/o Bakx Therapeutics Inc.
551 Mt Guardian Rd Ext, PO Box 398
Bearsville
NY
NEW YORK
12409
Director
Ervis
Gavathiotis
c/o Bakx Therapeutics Inc.
551 Mt Guardian Rd Ext, PO Box 398
Bearsville
NY
NEW YORK
12409
Executive Officer
Promoter
Loren
Walensky
c/o Bakx Therapeutics Inc.
551 Mt Guardian Rd Ext, PO Box 398
Bearsville
NY
NEW YORK
12409
Executive Officer
Promoter
Jessie
English
c/o Bakx Therapeutics Inc.
551 Mt Guardian Rd Ext, PO Box 398
Bearsville
NY
NEW YORK
12409
Executive Officer
Promoter
Frances
Toneguzzo
c/o Bakx Therapeutics Inc.
551 Mt Guardian Rd Ext, PO Box 398
Bearsville
NY
NEW YORK
12409
Promoter
Phillippe
Lopes-Fernandes
65 Quai George Gorse
Boulonge-Billancourt
I0
FRANCE
92100
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-08-20
false
true
true
false
0
34255728
20255728
14000000
Amount sold includes $4,255,728 attributable to Notes converted to Series A Preferred Stock.
false
3
0
0
0
false
Bakx Therapeutics, Inc.
/s/ Sree Kant
Sree Kant
Chief Executive Officer
2021-09-01